Literature DB >> 21393836

Inducible production of recombinant human Flt3 ectodomain variants in mammalian cells and preliminary crystallographic analysis of Flt3 ligand-receptor complexes.

Kenneth Verstraete1, Bert Remmerie, Jonathan Elegheert, Beatrice Lintermans, Guy Haegeman, Peter Vanhoenacker, Kathleen Van Craenenbroeck, Savvas N Savvides.   

Abstract

The extracellular complex between the haematopoietic receptor Flt3 and its cytokine ligand (FL) is the cornerstone of signalling cascades that are central to early haematopoiesis and the immune system. Here, efficient protocols for the production of two ectodomain variants of human Flt3 receptor, Flt3D1-D5 and Flt3D1-D4, for structural studies are reported based on tetracycline-inducible stable cell lines in HEK293S cells deficient in N-acetylglycosaminyltransferase I (GnTI-/-) that can secrete the target proteins with limited and homogeneous N-linked glycosylation to milligram amounts. The ensuing preparative purification of Flt3 receptor-ligand complexes yielded monodisperse complex preparations that were amenable to crystallization. Crystals of the Flt3D1-D4-FL and Flt3D1-D5-FL complexes diffracted to 4.3 and 7.8 Å resolution, respectively, and exhibited variable diffraction quality even within the same crystal. The resulting data led to the successful structure determination of Flt3D1-D4-FL via a combination of molecular-replacement and density-modification protocols exploiting the noncrystallographic symmetry and high solvent content of the crystals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393836      PMCID: PMC3053156          DOI: 10.1107/S1744309111003319

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  42 in total

1.  Identification and characterization of a functional murine FLT3 isoform produced by exon skipping.

Authors:  C Lavagna; S Marchetto; D Birnbaum; O Rosnet
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

Review 2.  Origin and development of dendritic cells.

Authors:  Kang Liu; Michel C Nussenzweig
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

3.  Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.

Authors:  Hitoshi Kiyoi; Ryuzo Ohno; Ryuzo Ueda; Hidehiko Saito; Tomoki Naoe
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

4.  FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells.

Authors:  Rui Zheng; Mark Levis; Obdulio Piloto; Patrick Brown; Brenda R Baldwin; Norbert C Gorin; Miloslav Beran; Zhenping Zhu; Dale Ludwig; Dan Hicklin; Larry Witte; Yiwen Li; Donald Small
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

5.  Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.

Authors:  N Maroc; R Rottapel; O Rosnet; S Marchetto; C Lavezzi; P Mannoni; D Birnbaum; P Dubreuil
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

6.  Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.

Authors:  Satoru Yuzawa; Yarden Opatowsky; Zhongtao Zhang; Valsan Mandiyan; Irit Lax; Joseph Schlessinger
Journal:  Cell       Date:  2007-07-27       Impact factor: 41.582

7.  Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.

Authors:  C Hannum; J Culpepper; D Campbell; T McClanahan; S Zurawski; J F Bazan; R Kastelein; S Hudak; J Wagner; J Mattson
Journal:  Nature       Date:  1994-04-14       Impact factor: 49.962

8.  Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression.

Authors:  Steve Barash; Wei Wang; Yanggu Shi
Journal:  Biochem Biophys Res Commun       Date:  2002-06-21       Impact factor: 3.575

9.  The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues.

Authors:  Claudia Waskow; Kang Liu; Guillaume Darrasse-Jèze; Pierre Guermonprez; Florent Ginhoux; Miriam Merad; Tamara Shengelia; Kaihui Yao; Michel Nussenzweig
Journal:  Nat Immunol       Date:  2008-05-11       Impact factor: 25.606

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  3 in total

Review 1.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

2.  Structural basis of the proinflammatory signaling complex mediated by TSLP.

Authors:  Kenneth Verstraete; Loes van Schie; Laurens Vyncke; Yehudi Bloch; Jan Tavernier; Ewald Pauwels; Frank Peelman; Savvas N Savvides
Journal:  Nat Struct Mol Biol       Date:  2014-03-16       Impact factor: 15.369

3.  Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma.

Authors:  Kenneth Verstraete; Frank Peelman; Harald Braun; Juan Lopez; Dries Van Rompaey; Ann Dansercoer; Isabel Vandenberghe; Kris Pauwels; Jan Tavernier; Bart N Lambrecht; Hamida Hammad; Hans De Winter; Rudi Beyaert; Guy Lippens; Savvas N Savvides
Journal:  Nat Commun       Date:  2017-04-03       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.